Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia
Tiffany W Chow1–6, Ariel Graff-Guerrero4,6, Nicolaas PLG Verhoeff2–4,7, Malcolm A Binns3,8, David F Tang-Wai5,9, Morris Freedman1,3,5, Mario Masellis5,10, Sandra E Black3,5,10, Alan A Wilson4,6, Sylvain Houle4,6, Bruce G Pollock4,61Division of Neurology, 2Department of Ps...
Main Authors: | Chow TW, Graff-Guerrero A, Verhoeff NP, Binns MA, Tang-Wai DF, Freedman M, Masellis M, Black SE, Wilson AA, Houle S, Pollock BG |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-07-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/open-label-study-of-the-short-term-effects-of-memantine-on-fdg-pet-in--a7870 |
Similar Items
-
Cognitive reserve hypothesis in frontotemporal dementia: A FDG-PET study
by: Leonie Beyer, et al.
Published: (2021-01-01) -
Value of 18F-FDG PET in differentiating Alzheimer's disease with frontotemporal dementia
by: Rui-xue CUI, et al.
Published: (2014-03-01) -
Using simultaneous PET/MRI to compare the accuracy of diagnosing frontotemporal dementia by arterial spin labelling MRI and FDG-PET
by: Udunna C. Anazodo, et al.
Published: (2018-01-01) -
Spectrum of clinical and FDG-PET patterns of patients with frontotemporal dementia (FTD) in a tertiary care hospital
by: Sundar Shanmugam, et al.
Published: (2021-06-01) -
Memantine for dementia.
by: Mcshane, R, et al.
Published: (2006)